Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Ardelyx Inc ARDX

Healthcare Biotechnology
Ardelyx, Inc. is a biopharmaceutical company. The Company focuses on discovery, development, and commercialization of advanced medicines that meet significant unmet medical needs. It has two commercial products IBSRELA (tenapanor) and XPHOZAH. Its product pipeline includes RDX013 Program and RDX020 Program. Tenapanor is a small molecule therapy in development for the treatment of or the control... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ARDX)

Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire 1 day ago

Ardelyx Responds to District Court Decision Granting Motion to Dismiss

GlobeNewswire 13 days ago

Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference

GlobeNewswire November 5, 2024

Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire October 31, 2024

Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology's (ACG) Annual Meeting

GlobeNewswire October 28, 2024

Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology's Kidney Week

GlobeNewswire October 24, 2024

Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community

GlobeNewswire October 22, 2024

Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community

GlobeNewswire October 21, 2024

Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024

GlobeNewswire October 17, 2024
View More News ››

Opinion & Analysis (NDAQ:ARDX)

Ardelyx's Shares Soar 65% as Tenapanor Phase 3 Study Hits the Mark

Streetwise Reports September 4, 2019

Why the election is not as relevant to drug stocks as you might believe

The Life Sciences Report November 4, 2016
View More Opinion ››

Bullboard Posts (NDAQ:ARDX)

What's Going On With Ardelyx Stock After Earnings? | Benzing

Breaking News: $ARDX What's Going On With Ardelyx Stock After Earnings? | BenzingaArdelyx, Inc. (NASDAQ:ARDX) shares are moving...
whytestocks - February 23, 2024

ARDX.....it took awhile but check it out

Volume & Price action..........$3.59
Iseneschal - March 3, 2023

ARDX.... Steady as she goes ; )

$3.10...... To the moon ?
Iseneschal - January 13, 2023

ARDX..... Been a constant staedy climb since June

Fiiling the gap..... Should be some news soon. Here is the last NR..... FDA Grants Appeal for Ardelyx's XPHOZAH ‚ ®...
Iseneschal - January 11, 2023

ARDX....did anyone other than me BTFD ?

Now over $3 Not a seller.... Cheers !
Iseneschal - January 11, 2023

ARDX ..... early a.m runner now in PB mode

Pick your spot..... I'm going to BTFD...sub $2.75  Cheers 
Iseneschal - January 9, 2023
View more Bullboard ››

LNG Energy Group Corp.

LNG Energy Group Corp.

LNG Energy Group Corp is a Canada-based company, which is focused on the acquisition and development of natural gas ...
View More »